click below
click below
Normal Size Small Size show me how
CNS 1
BDK
| Pharmacologic Category | Generic Name | Brand Name | Common Indication | Key Side Effects | USBW | Other Notes |
|---|---|---|---|---|---|---|
| Alpha2 antagonist | mirtazapine | Remeron | MDD | drowsiness, weight gain, xerostomia, increased appetite, constipation | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | --- |
| Norepinephrine-dopamine reuptake inhibitor | bupropion | Wellbutrin SR, Wellbutrin XL | MDD | tachycardia, headache, agitation, dizziness, insomnia, weight loss, xerostomia | increased risk of suicidal thinking and behavior in children, adolescents, and young children; serious neuropsychiatric reactions have occurred | use may increase risk of seizures (CI in patients w/ seizure disorders and/or eating disorders) |
| Selective norepinephrine reuptake inhibitor | atomoxetine | Strattera | ADHD | hypertension, tachycardia, headache, xerostomia, nausea, vomiting, constipation, decreased appetite, insomnia | increased risk of suicidal ideation in children or adolescents | CI within 14 days of MAOI |
| Serotonin-Norepinephrine reuptake inhibitor (SNRI) | desvenlafaxine | Pristiq | MDD | headache, xerostomia, nausea, vomiting, constipation, decreased appetite, insomnia, diaphoresis, hypertension, sexual dysfunction | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| Serotonin-Norepinephrine reuptake inhibitor (SNRI) | duloxetine | Cymbalta | MDD, neuropathic pain | headache, xerostomia, nausea, vomiting, constipation, decreased appetite, insomnia, diaphoresis, hypertension, sexual dysfunction | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| Serotonin-Norepinephrine reuptake inhibitor (SNRI) | venlafaxine | Effexor XR | MDD | headache, xerostomia, nausea, vomiting, constipation, decreased appetite, insomnia, diaphoresis, hypertension, sexual dysfunction | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| Selective Serotonin reuptake inhibitor (SSRI) | citalopram | Celexa | MDD | drowsiness, insomnia, nausea, vomiting, xerostomia, sexual dysfunction, headache, diaphoresis | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| Selective Serotonin reuptake inhibitor (SSRI) | fluoxetine | Prozac | MDD | drowsiness, insomnia, nausea, vomiting, xerostomia, sexual dysfunction, headache, diaphoresis | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI |
| Selective Serotonin reuptake inhibitor (SSRI) | escitalopram | Lexapro | MDD | drowsiness, insomnia, nausea, vomiting, xerostomia, sexual dysfunction, headache, diaphoresis | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| Selective Serotonin reuptake inhibitor (SSRI) | Paroxetine | Paxil | MDD | drowsiness, insomnia, nausea, vomiting, xerostomia, sexual dysfunction, headache, diaphoresis | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| Selective Serotonin reuptake inhibitor (SSRI) | Sertraline | Zoloft | MDD | drowsiness, insomnia, nausea, vomiting, xerostomia, sexual dysfunction, headache, diaphoresis | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| Serotonin reuptake inhibitor | trazodone | Desyrel | Insomnia, MDD | sedation, headache, dizziness, xerostomia, nausea, priapism | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | --- |
| Tricyclic antidepressant (TCA) | amitriptyline | Elavil | MDD, diabetic neuropathy, migraine prophylaxis | dizziness, drowsiness, orthostatic hypotension, sexual dysfunction, xerostomia, blurred vision, constipation | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| Tricyclic antidepressant (TCA) | nortriptyline | Pamelor | MDD, diabetic neuropathy, migraine prophylaxis | dizziness, drowsiness, orthostatic hypotension, sexual dysfunction, xerostomia, blurred vision, constipation | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |
| Tricyclic antidepressant (TCA) | doxepin | Silenor | Insomnia | somnolence, sedation, nausea | increased risk of suicidal thinking and behavior in children, adolescents, and young adults | CI within 14 days of MAOI; do not discontinue abruptly |